Table 2.
Positive rate of coinfection with respiratory viruses versus mono-infection in patients with URTIs and LRTIs.
| URTIs (number/percentage) | LRTIs (number/percentage) | |||||
|---|---|---|---|---|---|---|
| All | Mono-infection | Co-infection | All | Mono-infection | Co-infection | |
| ADV | 5/1.26 | 2/0.50 | 3/0.76 | 5/1.55 | 1/0.31 | 4/1.24 |
| HBoV | 2/0.50 | 0 | 2/0.50 | 27/8.36 | 12/3.72 | 15/4.64 |
| CoV | 8/2.02 | 5/1.26 | 3/0.76 | 10/3.1 | 1/0.31 | 9/2.79 |
| hMPV | 8/2.02 | 5/1.26 | 3/0.76 | 18/5.57 | 11/3.41 | 7/2.17 |
| IFV | 77/19.40 | 72/18.14 | 5/1.26 | 18/5.57 | 9/2.79 | 9/2.79 |
| IFVA | 58/14.61 | 54/13.60 | 4/1.01 | 13/4.02 | 8/2.48 | 5/1.55 |
| IFVB | 14/3.53 | 13/3.27 | 1/0.50 | 5/1.55 | 1/0.31 | 4/1.24 |
| IFVC | 5/1.26 | 5/1.26 | 0 | 0 | 0 | 0 |
| RSV | 3/0.76 | 1/0.25 | 2/0.50 | 32/9.91 | 13/4.02 | 19/5.88 |
| RSVA | 1/0.25 | 0 | 1/0.25 | 4/1.24 | 3/0.93 | 1/0.31 |
| RSVB | 2/0.50 | 1/0.25 | 1/0.25 | 28/8.67 | 10/3.10 | 18/5.57 |
| PIV | 43/10.83 | 32/8.06 | 11/2.77 | 85/26.32 | 44/13.62 | 41/12.69 |
| PIV1 | 13/3.27 | 10/2.51 | 3/0.76 | 12/3.72 | 4/1.24 | 8/2.48 |
| PIV2 | 1/0.25 | 1/0.25 | 0 | 0 | 0 | 0 |
| PIV3 | 24/6.05 | 16/4.03 | 8/2.02 | 67/20.74 | 37/11.46 | 30/9.29 |
| PIV4 | 5/1.26 | 5/1.26 | 0 | 6/1.86 | 3/0.93 | 3/0.93 |
| EV | 25/6.30 | 19/4.79 | 6/1.51 | 4/1.24 | 3/0.93 | 1/0.31 |
| RV | 42/10.58 | 33/8.31 | 9/2.27 | 90/27.86 | 43/13.32 | 47/14.55 |